|Articles|July 8, 2022
Robust AI Methods for Protein Biotherapeutics: VisualAI™ software for sample-agnostic image analysis with FlowCam
Author(s)Yokogawa Fluid Imaging Technologies
In our new white paper, we present detailed performance results for FlowCam's Artificial Intelligence software, VisualAI, using images of different protein aggregates including monoclonal and polyclonal antibodies and silicone oil that were obtained with multiple FlowCam 8100 instruments. We also demonstrate VisualAI’s effectiveness at measuring protein aggregate content in samples with known ratios of protein aggregates and silicone oil droplets.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How Mitigation and Maintenance Protect Against Future Risk
2
Charles River Incubator Cohort to Accelerate CGT Development
3
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
4
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
5
